BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30779420)

  • 1. The mouse as a model of fundamental concepts related to Turner syndrome.
    Arnold AP
    Am J Med Genet C Semin Med Genet; 2019 Mar; 181(1):76-85. PubMed ID: 30779420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution whole brain imaging of anatomical variation in XO, XX, and XY mice.
    Raznahan A; Probst F; Palmert MR; Giedd JN; Lerch JP
    Neuroimage; 2013 Dec; 83():962-8. PubMed ID: 23891883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome.
    Lopes AM; Burgoyne PS; Ojarikre A; Bauer J; Sargent CA; Amorim A; Affara NA
    BMC Genomics; 2010 Feb; 11():82. PubMed ID: 20122165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells.
    Urbach A; Benvenisty N
    PLoS One; 2009; 4(1):e4175. PubMed ID: 19137066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in Turner syndrome.
    Álvarez-Nava F; Lanes R
    Clin Epigenetics; 2018; 10():45. PubMed ID: 29636833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 39,XO mouse as a model for the neurobiology of Turner syndrome and sex-biased neuropsychiatric disorders.
    Lynn PM; Davies W
    Behav Brain Res; 2007 May; 179(2):173-82. PubMed ID: 17367875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-monosomy effects on visuospatial attention in mice: a candidate gene and implications for Turner syndrome and attention deficit hyperactivity disorder.
    Davies W; Humby T; Isles AR; Burgoyne PS; Wilkinson LS
    Biol Psychiatry; 2007 Jun; 61(12):1351-60. PubMed ID: 17161381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotype of a pig with monosomy X resembling Turner syndrome symptoms: a case report.
    Umeyama K; Nakano K; Matsunari H; Yamada T; Hasegawa K; Tang K; Tokuyama Y; Watanabe M; Nagaya M; Nagashima H
    J Reprod Dev; 2019 Jun; 65(3):231-237. PubMed ID: 30773506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategic research alliance: Turner syndrome and sex differences.
    San Roman AK; Page DC
    Am J Med Genet C Semin Med Genet; 2019 Mar; 181(1):59-67. PubMed ID: 30790449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on fear reactivity in XO mice are due to haploinsufficiency of a non-PAR X gene: implications for emotional function in Turner's syndrome.
    Isles AR; Davies W; Burrmann D; Burgoyne PS; Wilkinson LS
    Hum Mol Genet; 2004 Sep; 13(17):1849-55. PubMed ID: 15238507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature ovarian insufficiency in the XO female mouse on the C57BL/6J genetic background.
    Vaz B; El Mansouri F; Liu X; Taketo T
    Mol Hum Reprod; 2020 Sep; 26(9):678-688. PubMed ID: 32634219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetic variability in Turner syndrome linked to long-term clinical features.
    Suntharalingham JP; Ishida M; Cameron-Pimblett A; McGlacken-Byrne SM; Buonocore F; Del Valle I; Madhan GK; Brooks T; Conway GS; Achermann JC
    Front Endocrinol (Lausanne); 2023; 14():1227164. PubMed ID: 37800145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression level of Rps4 mRNA in 39,X mice and 40,XX mice.
    Omoe K; Endo A
    Cytogenet Cell Genet; 1994; 67(1):52-4. PubMed ID: 8187552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic imprinting and Turner syndrome.
    Bondy CA; Hougen HY; Zhou J; Cheng CM
    Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():728-32. PubMed ID: 22946286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic Analysis Identifies Potential Key Genes in the Pathogenesis of Turner Syndrome.
    Wang H; Zhu H; Zhu W; Xu Y; Wang N; Han B; Song H; Qiao J
    Front Endocrinol (Lausanne); 2020; 11():104. PubMed ID: 32210915
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome origins.
    Qi X; Wang Q; Yu M; Kong Y; Shi F; Wang S
    Front Endocrinol (Lausanne); 2023; 14():1024244. PubMed ID: 36733527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turner syndrome: the case of the missing sex chromosome.
    Zinn AR; Page DC; Fisher EM
    Trends Genet; 1993 Mar; 9(3):90-3. PubMed ID: 8488568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Turner syndrome patients within the Jordanian population, with a focus on four patients with Y chromosome abnormalities.
    Daggag H; Srour W; El-Khateeb M; Ajlouni K
    Sex Dev; 2013; 7(6):295-302. PubMed ID: 23988405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and genomics in Turner syndrome.
    Viuff M; Skakkebaek A; Nielsen MM; Chang S; Gravholt CH
    Am J Med Genet C Semin Med Genet; 2019 Mar; 181(1):68-75. PubMed ID: 30811826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-chromosome gene dosage and the risk of diabetes in Turner syndrome.
    Bakalov VK; Cheng C; Zhou J; Bondy CA
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3289-96. PubMed ID: 19567529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.